Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Balloul

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Memorias Do Instituto Oswaldo Cruz|January 1, 1987
GP38, P28-I and P28-II: candidates for a vaccine against schistosomiasisR J Pierce, J M Balloul, J M Grzych, et al.
Gene Therapy|September 23, 2000
Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx miceS Braun, C Thioudellet, P Rodriguez, et al.
The EMBO Journal|February 1, 1988
The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoniJ B Taylor, A Vidal, G Torpier, et al.
Parasite Immunology|September 1, 1991
Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoniD Boulanger, G D Reid, R F Sturrock, et al.
Journal of Clinical Microbiology|September 1, 1990
Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptidesC Auriault, H Gras-Masse, R J Pierce, et al.
Human Gene Therapy|July 26, 2000
Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragmentS Paul, D Snary, J Hoebeke, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancerS M Scholl, J M Balloul, G Le Goc, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Memorias Do Instituto Oswaldo Cruz|January 1, 1987
GP38, P28-I and P28-II: candidates for a vaccine against schistosomiasisR J Pierce, J M Balloul, J M Grzych, et al.
Gene Therapy|September 23, 2000
Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx miceS Braun, C Thioudellet, P Rodriguez, et al.
The EMBO Journal|February 1, 1988
The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoniJ B Taylor, A Vidal, G Torpier, et al.
Parasite Immunology|September 1, 1991
Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoniD Boulanger, G D Reid, R F Sturrock, et al.
Journal of Clinical Microbiology|September 1, 1990
Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptidesC Auriault, H Gras-Masse, R J Pierce, et al.
Human Gene Therapy|July 26, 2000
Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragmentS Paul, D Snary, J Hoebeke, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancerS M Scholl, J M Balloul, G Le Goc, et al.
Pageof 3